Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,830 | 27,920 | 27,920 | 16,743 | 7,443 |
| Marketable Securities | 7,480 | 8,750 | 8,750 | 6,006 | 6,252 |
| Other current assets | 410 | 450 | 450 | 232 | 433 |
| TOTAL | $42,720 | $37,120 | $37,120 | $22,981 | $14,128 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 3,300 | 3,120 |
| Other Non-Current Assets | 400 | 440 | 440 | 0 | 0 |
| TOTAL | $400 | $440 | $440 | $3,300 | $3,120 |
| Total Assets | $45,220 | $38,460 | $38,460 | $24,261 | $15,573 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,090 | 710 | 710 | 0 | 0 |
| Accrued Expenses | 520 | 410 | 410 | N/A | N/A |
| Other current liabilities | 60 | 750 | 750 | N/A | N/A |
| TOTAL | $2,300 | $2,070 | $2,070 | $2,414 | $1,586 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,300 | $2,070 | $2,070 | $2,414 | $1,586 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -36,870 | -33,710 | -33,710 | N/A | N/A |
| Other shareholders' equity | -11 | -11 | -11 | 21,846 | 13,987 |
| TOTAL | $42,910 | $36,380 | $36,380 | $21,847 | $13,988 |
| Total Liabilities And Equity | $45,210 | $38,450 | $38,450 | $24,261 | $15,574 |